Stephen A Hill - Net Worth and Insider Trading
Stephen A Hill Net Worth
The estimated net worth of Stephen A Hill is at least $41,390 dollars as of 2024-04-24. Stephen A Hill is the Director of Lipocine Inc and owns about 5,250 shares of Lipocine Inc (LPCN) stock worth over $25,200. Stephen A Hill is the Director of Catalyst Biosciences Inc and owns about 1,381 shares of Catalyst Biosciences Inc (CBIO) stock worth over $10,592. Stephen A Hill is also the Director of Cellectar Biosciences Inc and owns about 1,800 shares of Cellectar Biosciences Inc (CLRB) stock worth over $5,598. Details can be seen in Stephen A Hill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen A Hill has not made any transactions after 2020-06-04 and currently still holds the listed stock(s).
Transaction Summary of Stephen A Hill
Stephen A Hill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen A Hill owns 4 companies in total, including Cellectar Biosciences Inc (CLRB) , Lipocine Inc (LPCN) , and Catalyst Biosciences Inc (CBIO) among others .
Click here to see the complete history of Stephen A Hill’s form 4 insider trades.
Insider Ownership Summary of Stephen A Hill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLRB | Cellectar Biosciences Inc | 2020-06-04 | director |
| LPCN | Lipocine Inc | 2017-12-29 | director |
| CBIO | Catalyst Biosciences Inc | 2015-12-17 | director & President & CEO |
| ARQL | Arqule Inc | 2007-10-04 | director & President and CEO |
Stephen A Hill Latest Holdings Summary
Stephen A Hill currently owns a total of 3 stocks. Among these stocks, Stephen A Hill owns 5,250 shares of Lipocine Inc (LPCN) as of December 29, 2017, with a value of $25,200 and a weighting of 60.88%. Stephen A Hill owns 1,381 shares of Catalyst Biosciences Inc (CBIO) as of December 17, 2015, with a value of $10,592 and a weighting of 25.59%. Stephen A Hill also owns 1,800 shares of Cellectar Biosciences Inc (CLRB) as of June 4, 2020, with a value of $5,598 and a weighting of 13.53%.
Latest Holdings of Stephen A Hill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LPCN | Lipocine Inc | 2017-12-29 | 5,250 | 4.80 | 25,200 |
| CBIO | Catalyst Biosciences Inc | 2015-12-17 | 1,381 | 7.67 | 10,592 |
| CLRB | Cellectar Biosciences Inc | 2020-06-04 | 1,800 | 3.11 | 5,598 |
Holding Weightings of Stephen A Hill
Stephen A Hill Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen A Hill has made a total of 0 transactions in Lipocine Inc (LPCN) over the past 5 years. The most-recent trade in Lipocine Inc is the sale of 1,250 shares on December 29, 2017, which brought Stephen A Hill around $4,338.
According to the SEC Form 4 filings, Stephen A Hill has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the acquisition of 333 shares on December 17, 2015, which cost Stephen A Hill around $10,150.
According to the SEC Form 4 filings, Stephen A Hill has made a total of 1 transactions in Cellectar Biosciences Inc (CLRB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cellectar Biosciences Inc is the acquisition of 1,800 shares on June 4, 2020, which cost Stephen A Hill around $19,440.
Insider Trading History of Stephen A Hill
- 1
Stephen A Hill Trading Performance
GuruFocus tracks the stock performance after each of Stephen A Hill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen A Hill is 8.73%. GuruFocus also compares Stephen A Hill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen A Hill within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen A Hill's insider trading performs compared to the benchmark.
Performance of Stephen A Hill
Average Return
1.5%
Outperforming Transactions
80%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 21.07 | 8.73 | 24.29 | 1.5 | -30.4 | -49.98 |
| Relative Return to S&P 500(%) | 22.06 | 4.25 | 16.45 | -18.22 | -44.63 | -59.68 |
Stephen A Hill Ownership Network
Ownership Network List of Stephen A Hill
Ownership Network Relation of Stephen A Hill
Stephen A Hill Owned Company Details
What does Cellectar Biosciences Inc do?
Who are the key executives at Cellectar Biosciences Inc?
Stephen A Hill is the director of Cellectar Biosciences Inc. Other key executives at Cellectar Biosciences Inc include Senior Vice President & Medical Andrei Shustov , Chief Commercial Officer Darrell Shane Lea , and Chief Financial Officer Chad J Kolean .
Cellectar Biosciences Inc (CLRB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cellectar Biosciences Inc Insider Transactions
Stephen A Hill Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen A Hill. You might contact Stephen A Hill via mailing address: 50 Avenue General De Gaulle, Bruxelles C9 9999999999.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
